2024 |
Iterum Therapeutics Plc
|
Director, President and Chief Executive Officer |
- |
- |
2023 |
Iterum Therapeutics Plc
|
Director, President and Chief Executive Officer |
1.5 M |
10.6 % |
2022 |
Iterum Therapeutics Plc
|
Director, President and Chief Executive Officer |
1.4 M |
-86.5 % |
2021 |
Iterum Therapeutics Plc
|
Director, President and Chief Executive Officer |
10.9 M |
519.8 % |
2021 |
Iterum Therapeutics Plc
|
- |
10.2 M |
480.6 % |
2020 |
Iterum Therapeutics Plc
|
- |
1.8 M |
26.0 % |
2020 |
Iterum Therapeutics Plc
|
Director, President and Chief Executive Officer |
1.8 M |
26.0 % |
2020 |
Iterum Therapeutics Plc
|
- |
1.8 M |
26.0 % |
2019 |
Iterum Therapeutics Plc
|
- |
1.4 M |
-20.8 % |
2019 |
Iterum Therapeutics Plc
|
Director and Chief Executive Officer |
1.4 M |
-20.8 % |
2019 |
Iterum Therapeutics Plc
|
- |
1.4 M |
-20.8 % |
2018 |
Iterum Therapeutics Plc
|
Director and Chief Executive Officer |
1.8 M |
132.7 % |
2018 |
Iterum Therapeutics Plc
|
- |
1.8 M |
132.7 % |
2018 |
Iterum Therapeutics Plc
|
- |
1.8 M |
132.7 % |
2017 |
Iterum Therapeutics Plc
|
- |
754.9 K |
- |
2017 |
Iterum Therapeutics Plc
|
- |
754.9 K |
- |
2017 |
Iterum Therapeutics Plc
|
President, Chief Executive Officer and Director |
754.9 K |
- |